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Abstract
The adenine nucleotide translocase (ANT) mediates the exchange of ADP and ATP across the inner mitochondrial
membrane. The human genome encodes multiple ANT isoforms that are expressed in a tissue-specific manner. Recently a
novel germ cell-specific member of the ANT family, ANT4 (SLC25A31) was identified. Although it is known that targeted
depletion of ANT4 in mice resulted in male infertility, the functional biochemical differences between ANT4 and other
somatic ANT isoforms remain undetermined. To gain insight into ANT4, we expressed human ANT4 (hANT4) in yeast
mitochondria. Unlike the somatic ANT proteins, expression of hANT4 failed to complement an AAC-deficient yeast strain for
growth on media requiring mitochondrial respiration. Moreover, overexpression of hANT4 from a multi-copy plasmid
interfered with optimal yeast growth. However, mutation of specific amino acids of hANT4 improved yeast mitochondrial
expression and supported growth of the AAC-deficient yeast on non-fermentable carbon sources. The mutations affected
amino acids predicted to interact with phospholipids, suggesting the importance of lipid interactions for function of this
protein. Each mutant hANT4 and the somatic hANTs exhibited similar ADP/ATP exchange kinetics. These data define
common and distinct biochemical characteristics of ANT4 in comparison to ANT1, 2 and 3 providing a basis for study of its
unique adaptation to germ cells.
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Introduction
The adenine nucleotide translocase (ANT) mediates the
exchange of ADP and ATP across the inner mitochondrial
membrane. Therefore, proper function of ANT is essential for the
transfer of ATP synthesized in mitochondria to the cytoplasm.
Most eukaryotes from yeast to humans have multiple ANT
isoforms [1]. Unicellular organisms utilize different ANT isoforms
depending on the availability of external nutrients and aeration.
Multicellular organisms, express different ANT isoforms in a
tissue-specific manner that are apparently adapted to the unique
metabolic demands of the various tissues.
Recently, we and others identified a novel member of the ANT
family, ANT4 (SLC25A31, AAC4, SFEC) in both humans and
mice [2,3,4]. ANT4 is evolutionarily conserved in mammals and
exclusively expressed in male germ cells of adult animals [5].
Although the previous gene knock-out study in mouse revealed that
ANT4 was essentialfortheprocessofmale germcellmeiosis inmice
[6], neither the function of ANT4 in male germ cells nor the reason
whyANT4 existsonlywithina limited spectrumofspeciesis known.
The human ANT4 gene (hANT4) is predicted to encode a 315
amino acid protein. The protein contains the characteristic amino
acid sequence (RRRMMM) shared by all known ADP/ATP
carriers. hANT4 was demonstrated to possesses bona fide ADP/
ATP transport upon reconstitution and assay of recombinant
protein from E. coli into proteo-liposomes [3]. The reported
kinetics of hANT4 were distinct from previously reported kinetics
of other somatic hANTs, with comparatively lower affinity for
adenine nucleotides and a higher Vmax. Unfortunately, the kinetics
of ADP/ATP transport through hANT4 and somatic hANTs were
not compared under comparable experimental conditions. There-
fore, it is important to evaluate the differing biochemical
characteristics of hANT4 and the somatic hANTs to elucidate
the functional role of hANT4.
In order to determine the biochemical properties of the hANT4,
we have chosen to heterologously express each hANT isoform in
yeast and analyze their biochemical properties in parallel. Baker’s
yeast, Saccharomyces cerevisiae contains three paralogous genes
encoding ADP/ATP carriers: AAC1, AAC2 and AAC3. Yeast
AACs have been extensively studied, taking advantage of the
myriad molecular and genetic tools available in this organism [7].
The mitochondrial ADP/ATP exhange acitivity is not essential for
cell growth under fermentation culture conditions and becomes
essential only under non-fermentation conditions. This unique
system provided the means to knock-out all three native AAC
genes and insert heterologous hANT genes. The function of ADP/
ATP exhange acitivity can be readily determined by following
growth on non-fermentable carbon sources. Moreover, the
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mitochondria [8,9].
Here we expressed hANT4 protein in AAC- deficient yeast
mitochondria along with somatic hANTs for parallel comparison.
Using a similar methodology to that required for functional
hANT1, 2 and 3 expression in yeast, hANT4 failed to complement
the respiratory defect of yeast lacking the endogenous AAC genes.
Moreover, overexpression of hANT4 led to deleterious effects on
yeast cell growth. However, mutant forms of hANT4 protein were
isolated that facilitated proper mitochondrial localization and
complementation of AAC-deficient yeast. The ADP/ATP ex-
change kinetics of those modified hANT4 proteins compared
favorably to the kinetics of the somatic hANTs expressed and
analyzed under identical experimental conditions.
Results
Introduction of the human ANT gene into the AAC2
locus
We initially attempted to insert the full length hANT4 coding
sequence into AAC-deficient yeast by homologous recombination
at the AAC2 locus. The idea was to select transformants based on
their ability to grow on media requiring a functional mitochondrial
respiratory system by providing sufficient adenine nucleotide
transport activity to support growth of yeast on nonfermentable
carbon sources as described previously [10]. A codon-optimized
hANT4 ORF was amplified by PCR with primers that provided
50 bp of identity to the sequences immediately 59 and 39 of the
AAC2 start and stop codons. The amplified DNA was transformed
into the AAC-deficient yeast strain bearing the KAN-MX6 genetic
marker at the AAC2 locus. All yeast strains in this study bear
deletions of the AAC1 and AAC3 and are derived from strain
TCY119 (Table 1). As controls, either AAC2 or hANT2 sequences
were similarly prepared by PCR and used to generate knock-ins at
the same locus. Only the AAC2 knock-in transformants appeared
and grew on nonfermentable media (YPEG), suggesting that
neither hANT2 nor hANT4 knocked-in at this locus supported
respiratory growth. Previously, it was found that addition of the
N-terminal sequence from yeast AAC2 to the cognate position of
bovine ANT1 significantly increased expression in yeast [11].
Therefore, we constructed chimeric hANT genes in which N-
terminal sequences were replaced with the AAC2 N-terminal 25
amino acids (yNhANTs) and repeated the knock-in protocol.
Using this methodology, the yNhANT2 knock-in transformant
clones could be isolated, and these yeast grew on YPEG. In
contrast, yNhANT4 knock-in transfomants again failed the
selection protocol.
To insert the hANT4 gene into the yeast AAC2 independent of
its ability to complement the ATP/ADP exchange function, a two-
step strategy was adopted (Fig. 1). First, the KAN-MX6 marker
present at the AAC2 locus of TCY119 was replaced with the
common yeast selectable marker URA3 (‘‘URA3-AAC2’’ in
Fig. 1). In the second step, each hANT knock-in construct was
transformed into the URA3-AAC2 strain to allow homologous
recombination at URA3-AAC2 site. Transformants were identi-
fied by selecting for 5-FOA resistance on rich glucose media. Yeast
lacking the URA3 gene are resistant to the cyotoxic effects of 5-
FOA [12]. In this way, yeast strains carrying yNhANT4 gene at
the AAC2 locus were successfully isolated and propagated
(yNhANT4). yNhANT1, 2, 3 and AAC2 expressing strains were
similarly generated (Fig. 2A). All yeast strains were capable of
growth on fermentable carbon sources (YPD, rich-glucose media)
(Fig. 2B). AAC2 and yNhANT1, 2, 3 knock-in yeast displayed
abundant growth on nonfermentation culture conditions (YPEG).
However, yNhANT4 did not grow on YPEG when directly
streaked from YPD grown cells (Fig. 2C). Even after incubation for
over 1 week, yNhANT4 strain did not grow on YPEG (Fig. 2D).
We concluded that modifying the N-terminus of hANT4 with
AAC2 N-terminal sequences was not sufficient to provide adequate
translocator activity for growth of yeast on nonfermentable carbon
sources.
Effects of excessive expression of hANT4
We suspected that hANT4 expression from a single copy at the
AAC2 locus might be insufficient to compensate for the loss of
Table 1. Yeast strains used in this study.
Strain
a Genotype
b
TCY119
c MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::kanMX6 aac3-D1::hisG [r+, TRP1]
URA-AAC MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::URA3 aac3-D1::hisG [r+, TRP1]
yAAC2 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-AAC2 aac3-D1::hisG [r+,T R P 1 ]
yNhANT1 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT1 aac3-D1::hisG [r+,T R P 1 ]
yNhANT2 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT2 aac3-D1::hisG [r+,T R P 1 ]
yNhANT3 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT3 aac3-D1::hisG [r+,T R P 1 ]
yNhANT4 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4 aac3-D1::hisG [r+,T R P 1 ]
yNhANT4 A30V MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4 (A30V) aac3-D1::hisG [r+, TRP1]
yNhANT4 P95S MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4 (P95S) aac3-D1::hisG [r+, TRP1]
yNhANT4 P95L MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4 (P95S) aac3-D1::hisG [r+, TRP1]
yNhANT4 S202L MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4 (S202L) aac3-D1::hisG [r+, TRP1]
yNhANT4 V5 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4-V5::KanR aac3-D1::hisG [r+, TRP1]
yNhANT4 A30V V5 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4-V5 (A30V)::KanR aac3-D1::hisG [r+, TRP1]
yNhANT4 S202L V5 MATa ura3–52 leu2–3, 112 trp1-D1 ade2 his3-D1::hisG aac1-D1::hisG aac2-D1::6xHis-yNhANT4-V5 (S202L)::KanR aac3-D1::hisG [r+,T R P 1 ]
aUnless indicated, all strains were created in this study.
bMitochondrial genome is bracketed.
cStrain source: [10].
doi:10.1371/journal.pone.0019250.t001
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expression was increased by transforming yeast with a high-copy
plasmid, pESC-Leu2d [13] bearing the yNhANT4 gene. This
plasmid, pESC-Leu2d::yNhANT4, is maintained both at high
copy and expresses the gene under control of the strong Gal1
promoter. pESC-Leu2d::yNhANT2, a similarly constructed con-
trol plasmids with yNhANT2, or the empty vector were
introduced into the triple AAC knock-out yeast (URA3-AAC2)
(Fig. 3). The transformed yeast were incubated on glucose media
lacking leucine (Fig. 3A), galactose media which induces
expression of the respective ANT genes (Fig. 3B), and media
containing a nonfermentable carbon source (Fig. 3C). When
yNhANT4 expression was induced by addition of galactose, yeast
cell growth was suppressed (Fig. 3B). Overexpression of yNhANT2
did not affect the growth on the fermentable carbon source
galactose, and indeed yNhANT2 overexpression supported growth
on nonfermentable carbon sources (Fig. 3C). These observations
led us to conclude that the overexpression of yNhANT4 was
unfavorable, and that further modification of yNhANT4 or the
yeast genome would be required for functional reconstitution of
yNhANT4 in yeast.
EMS mutagenesis and functional screening of yNhANT4
yeast
The AAC2 promoter is highly induced when yeast are
transferred from fermentable to nonfermentable carbon sources
[14]. Therefore, we hypothesized that while the lower yNhANT4
expression of glucose grown cells does not adversely affect cell
growth, higher expression in YPEG may be inhibitory. To combat
this putative intolerance to the heterologous protein, we isolated
mutant forms of yNhANT4 that allowed yeast to grow on
nonfermentable carbon sources. After treating yNhANT4 yeast
strains with the mutagen EMS, four independent mutant strains
were isolated that were capable of respiratory growth. The AAC2/
yNhANT4 locus of each was subjected to DNA sequencing and
each contained a point mutation in the yNhANT4 ORF that
changed a single amino acid (Table 2). Alignment of the human
ANT isoforms, yeast AAC isoforms and bovine ANT1 revealed
that the hANT4 amino acid sequence is more than 70% identical
to other mammalian ANT isoforms and more than 50% identical
to the yeast AACs. The putative substrate binding sites as well as
the signature RRRMMM motif are highly conserved between the
isoforms and across species (Fig. 4). The three amino acid residues
that were the sites of mutation in hANT4 that allowed
complementation of AAC-deficient yeast varied in their degrees
of conservation. A30 of hANT4 is conserved among mammals
across all ANT isoforms but not conserved in yeast. P95 of hANT4
is conserved in all ANT related sequences. S202 of hANT4 is
unique to ANT4 protein in all mammalian species examined
(chimpanzee, cow, dog, mouse, rat and opossum) (data not shown).
We determined that the mutations in yNhANT4 were indeed
responsible for the growth complementation on YPEG by
reintroducing the mutated yNhANT4 alleles back into the
parental strain. All the four alleles supported yeast growth on
YPEG. The A30V mutation of yNhANT4 proved the strongest
allele by showing rapid growth on nonfermentable carbon sources
comparable to that of yeast bearing the wild-type yeast allele AAC2
(Fig. 5). Although each amino acid mutation within yNhANT4
was sufficient to complement growth on nonfermentable carbon
sources, the mutant yeasts that were originally recovered from
EMS mutagenesis might have contained additional mutations
outside of the yNhANT4 that also contributed to improved growth
on nonfermentable carbon sources. To test this hypothesis, the
mutant yNhANT4 locus for three of the isolates was first replaced
by URA3, and then wild type yNhANT4 was reintroduced using 5-
FOA selection as described above. None of the mutants bearing
the non-mutated yNhANT4 allele could support growth on
nonfermentable carbon sources. Therefore, we concluded that the
A30V, P95S and S202L amino acid substitutions were sufficient
for functional expression in yeast.
Improved mitochondrial expression in hANT4 mutant
strains
To further investigate the role of amino acid residues A30, P95
and S202 in yNhANT4, we analyzed yNhANT4 transcript and
protein levels in isogenic parent and mutant yeast strains. The V5-
tag was added to the C-terminus of yNhANT4 and mutant
yNhANT4 genes to allow detection of yNhANT4 protein. The
presence of the V5-tags did not alter the growth characteristics on
YPD or YPEG in comparison to the parental untagged strains.
The yNhANT4-V5 yeast strains were cultured using the same
media, rich glucose-containing media (YPD). When the transcript
levels of the yNhANT4 gene from each strain were compared by
real-time PCR, there were no significant differences between the
parent and mutants (Fig. 6A). However, western blot analysis using
anti-V5 antibody on whole cells and isolated mitochondria
revealed that the amount of yNhANT4 protein in mitochondria
was lower in the native yNhANT4-V5 strains than the A30V and
S202L mutant strains (Fig. 6B). We also confirmed that yNhANT4
protein expression levels in P95S and P95L strains were similar to
those in A30V and S202L strains in western blot analysis using
anti-His antibody (data not shown). Based upon these observa-
tions, the increased amount of yNhANT4 protein found in
Figure 1. Strategy for introduction of hANTs into the AAC2
locus. Step1: KAN-MX6 cassette at the AAC2 locus in AAC triple mutant
yeast (TCY119) was replaced with URA3 to establish the parent stain
(URA-AAC2). Step2: PCR-generated N-terminal AAC + hANTs ORF
fragments (yNhANTs) were used for transformation of URA-AAC2, and
transformants were selected on rich glucose media containing 5-FOA.
doi:10.1371/journal.pone.0019250.g001
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tional event.
ADP/ATP exchange kinetics of hANT4
The ADP/ATP exchange kinetics of hANT4 was compared to
the other somatic hANT isoforms. Mitochondria were prepared
from hANT expressing yeast grown on nonfermentable carbon
sources, and the efflux rate of ATP was measured as a function of
changes in external ADP concentration. A representative hANT4
A30V kinetic curve is shown in Fig. 7 and the kinetic parameters
obtained from each hANT are summarized in Table 3. All ATP/
ADP translocators tested (hANT1, 2, 3, 4 and yeast AAC2) have a
KM for ADP in the micromolar range, consistent with previously
reported values [8]. The hANT4 KM values varied several fold
depending on the particular allele of hANT4, with two of the three
mutant proteins (A30V and S202L) showing lower KM values for
ADP than hANT1, 2 and 3. Interestingly, the difference found in
the kinetic parameters of the mutant hANT4 proteins correspond-
ed to the relative growth rates of yeast on nonfermentable carbon
sources (Figure 5). The hANT4 bearing the A30V mutant form
was fastest growing and has a low KM and high Vmax. Mutant
hANT4 proteins that supported growth less well on nonfermen-
table carbon sources had either a greater KM (P95S) or smaller
Vmax (S202L).
Discussion
Saccharomyces cerevisiae has proven to be a useful experimental
system for investigating the fundamental biochemical properties of
ADP/ATP exchange across the inner mitochondrial membrane
[7]. Since mitochondrial ADP/ATP exhange acitivity in yeast is
not essential during fermentative growth but is essential for growth
using nonfermentable carbon sources, it was possible to introduce
and biochemically analyze nonfunctional or sub-functional ANTs.
Consequently, we were able to knock-out all three native AAC
genes and insert heterologous genes corresponding to hANT1, 2,
3, and 4 at the yeast AAC2 locus.
There are some limitations of this heterologous expression
method. Several previous reports as well as data presented here
demonstrated that the N-terminal sequence greatly influences the
functional localization of ANT proteins [15]. Apparently the
mammalian ANT proteins lack a necessary signal for compatibility
with the yeast mitochondrial inner membrane protein transport
Figure 2. Characterization and growth of humanized-ANT yeast strains. (A) Confirmation of hANT gene insertion by PCR-restriction
fragment length analysis. AAC2 locus was PCR amplified by primers positioned 59 and 39 of ORF. The fragments were digested with BglII and EcoRI,
and separated on a 2% agarose gel. (B) Growth of hANT yeast on complete glucose medium (YPD). (C) Growth of hANT yeast on complete ethanol-
glycerol medium (YPEG). (D) Growth curves of hANT yeast in YPEG determined by turbidity (O.D.600).
doi:10.1371/journal.pone.0019250.g002
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for functional expression in yeast mitochondria. These mutations
were all missense mutations affecting A30, P95 or S202 in hANT4
protein and improved yeast mitochondrial expression. Without
these modifications, hANT4 protein was unstable in yeast (Fig. 6).
Accumulation of excess unfolded protein could be the reason that
over-production of the yNANT4 protein suppressed the yeast cell
growth (Fig. 3).
It remained unclear how the specific amino acid substitution at
the residues (A30, P95 and S202) allowed functional expression in
yeast mitochondria. Therefore, we mapped these amino acids onto
a three-dimensional structure of hANT4, using the sequence
alignments and the crystal structure of bovine ANT1 [16] as a
guide (Fig. 4 and 8). Interestingly, all three mutation sites were
located in transmembrane domains and are predicted to be
located at similar levels with respect to the mitochondrial
membrane. All three sites are oriented towards solvent, and two
of the sites (P95S and S202L) are located in positions that may
permit interaction with lipid since these residues are in close
proximity to the LAPAO detergent in the crystal structure of
ANT1 [16]. Indeed, both substitutions of A30V and S202L
increase hydrophobicity of these sites. The substitution of P95S
might impose flexibility to fit the yeast lipid environment. It should
be noted that the substitution of P89L in AAC1 that corresponds to
the P95L substitution in hANT4 has shown to alter functionality of
the protein in the native phospholipid environment of yeast [17].
A previous study demonstrated that modifications of amino acids
of somatic hANT proteins near a putative cardiolipin interaction
site improved yeast growth in reduced oxgen conditions, and
suggested that differences of lipid composition between the
mitochondrial inner membranes of yeast and mammals might
limit proper function [18].
Since ANT4 is exclusively found in mammalian germ cells and
sperm mitochondria, it is reasonable to speculate that hANT4 may
have evolved to adapt to the lipid environment of those cell types.
Interestingly, the relatively subtle amino acid changes isolated in
hANT4 influenced the ADP/ATP exchange kinetics even though
those changes occurred far from the substrate binding site (Table
3). This may also suggest that subtle changes in lipid composition
of inner membrane may alter hANT function. Indeed, cardiolipin
is a critical component for exchange activity in both yeast and
mammalian ANT [19,20]. Levels of phospholipids and cholesterol
have also been shown to affect the exchange function of
mammalian ANTs [21]. In the case of ANT4, oxidation or other
damage to lipids could alter the exchange function of ANT4, and
potentially affect male germ cell meiosis or sperm motility.
It is technically challenging to determine the ADP/ATP
exchange kinetics of ANT proteins, which are influenced by
various factors depending on the methodology. Therefore, the
kinetic values vary considerably in literature [7]. The previously
reported transport kinetics of hANT4 had higher KM values,
72 mM for ADP and 120 mM for ATP in a liposome reconstitution
system using purified hANT4 [3]. In the present study, we found
that the KM values were much lower in all three mutant hANT4
Figure 3. Over-production of yNhANT4 by high-copy plasmid inhibits yeast cell growth. Both yNhANT4 and yNhANT2 ORF were cloned
into a high-copy plasmid and expressed under the control of the GAL1 promoter. Three independent isolates, each transformed with one of the
indicated plasmids (Empty plasmid, yNhANT4, and yNhANT2) were streaked on medium as indicated. (A) glucose medium, (B) galactose medium,
and (C) YPEG + 0.1% galactose.
doi:10.1371/journal.pone.0019250.g003
Table 2. Summary of mutation sites that facilitate functional expression of yNhANT4 in yeast.
No. Strain Nucleotide change Amino acid change Corresponding position in
hANT 1, 2 and 3 AAC2
1 yNhANT A30V GCT to GTT A30V A18 S33
2 yNhANT P95S CCA to TCA P95S P83 P99
3 yNhANT P95L CCA to CTA P95L P83 P99
4 yNhANT S202L TCA to TTA S202L A190 L206
doi:10.1371/journal.pone.0019250.t002
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3). Although our hANT4 peptides contain mutations required for
proper assembly and stability of the proteins in yeast mitochon-
drial membrane, these mutation sites are distant from the ADP/
ATP binding pocket and unlikely to substantially change the
substrate binding affinity per se. Indeed, the substitution of A18V in
hANT2 protein, corresponding to A30V in hANT4, did not
significantly change the kinetics of ADP/ATP in yeast mitochon-
dria (data not shown). To this end, our data suggest that properly
assembled hANT4 protein may have similar ADP/ATP exchange
kinetics with those of the somatic hANTs.
In this study, native AAC2 ORF was replaced with hANT
sequences by homologous recombination. There is a distinct
advantage to having a chromosomally borne transgene as an
expression system as compared to a plasmid-based system. Using
the experimental design described here, all cells in the culture
contained the transgene and expressed it at the same level. In
contrast, plasmid numbers vary from cell-to-cell with as many as
50% of cells in a culture under selection lacking the plasmid. This
is particularly important for physiological studies of carbon source
utilizations, studies that require transitions between growth
conditions or media, and purification of proteins from large batch
cultures. This yeast expression system can be used as a starting
source to obtain structural information of hANT proteins.
Additionally, these yeast strains will be a useful tool for high-
throughput screening in drug discovery [22]. Small compounds
identified in this way that specifically inhibit hANT4 function may
have use as male contraceptives.
To date, there is no evidence of hANT4 gene mutations
associated with a human disease. However, recent advances in
sequencing technology have documented millions of novel SNP
variants from large populations [23]. So far 18 hANT4 variants
have been archived in the database, including 6 non-synonymous
variants in the coding region. It will be interesting to see if any of
those variants correlate with pathology. Association of any of these
variants with a particular diseases must await further progress on
genome-wide association studies and whole genome sequencing
projects for specific diseases [24]. If a certain hANT4 variant is
found to be associated with a human disease, functional
Figure 5. Growth of various yNhANT4 mutant yeasts on
nonfermentable carbon sources. The hANT4 mutant alleles that
complemented the aacD yeast were re-introduced into the parent yeast
(URA-AAC2). The yeast strains were cultured in rich nonfermentable
carbon source media (YPEG) at 30uC for the indicated time. Growth was
monitored by turbidity (O.D.600).
doi:10.1371/journal.pone.0019250.g005
Figure 4. Primary amino acid sequence alignment of various ANTs. A30, P95 and S202 of hANT4 are indicated by arrow. Transmembrane
domains are shown as shaded sequences.
doi:10.1371/journal.pone.0019250.g004
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system and techniques described here.
Materials and Methods
Strains and media
All S. cerevisiae strains were derived from D273-10B and the
genotypes of strains used in this study are summarized in Table 1
[10]. Yeast strains were grown in a variety of media. Complete
glucose medium (YPD) contained 2% glucose, 2% bacto peptone,
1% yeast extract, 40 mg/liter adenine, 40 mg/liter tryptophan.
Complete ethanol-glycerol medium (YPEG) contained 3%
glycerol, 3% ethanol, 2% bacto peptone, 1% yeast extract, 40
adenine, 40 mg/liter tryptophan. Synthetic dextrose medium (SD)
was 2% glucose, 6.7 g/liter yeast nitrogen base without amino
acids (Difco), supplemented with yeast synthetic drop-out media
and/or appropriate amino acids, adenine, and uracil (Sigma). For
solid media, bacto agar (Difco) was added at 18 g/liter. 5-
fluoroorotic acid (5FOA) was added as appropriate at 1 g/liter
(Zymo) or geneticin (G418) was added at 200 mg/ml.
Insertion of URA3 gene into the AAC2 locus
Generation of triple null mutations of AAC1, AAC2 and AAC3
(TCY119) was previously described [10]. In TCY119, the AAC2
locus was disrupted by a KAN-MX6 cassette imparting resistance
to geneticin. We replaced the KAN-MX6 cassette with the URA3
to allow knock-in hANT genes via homologous recombination
using 5-FOA selection. To target the URA3 gene to the AAC2
locus, a URA3 cassette was generated containing DNA fragment
flanked by sequence homologous to the ,200 bp immediately up-
and downstream of the AAC2 ORF [25]. Briefly, AAC2 ORF
upstream and downstream sequences were amplified by PCR
using primer set F1+R1 and F2+R2 separately. The URA3 was
amplified using primer set U1+U2, which contained the reverse
complement sequence of either R1 or F2. Purified PCR fragments
were annealed and amplified by the primer set F1+R2. The PCR-
generated DNA fragments were used to transform TCY119 by the
LiAc/SS Carrier DNA/PEG method [10]. Transformants were
selected on SD plates lacking uracil. Insertion of URA3 into the
AAC2 locus of the yeast (URA-AAC2) was verified by PCR and
subsequent sequencing. Primer sequences denoted above are listed
in supplemental Table S1.
hANT1, 2, 3 and 4 knock-ins in the AAC2 locus
All hANT knock-in DNA fragments were constructed using the
same PCR strategy described above. To amplify ORFs for
hANT1, 2 and 3, human cDNAs were used as the PCR template.
For the hANT4, a codon-optimized hANT4 ORF for expression
in yeast was synthesized (MR. GENE GmbH) and used as a
template. The hANT4 ORF sequences used in this study are
shown in supplemental Figure S1. For making the 6X histidine
tagged yeast AAC2, genomic DNA (TCY122) was amplified by
PCR with primer sets F1+HisR and HisF+R2. Purified products
were combined and further amplified using primer set F1+R2.
The PCR products were transformed into URA-AAC2 followed
Figure 6. Mutations increase mitochondrial ANT4 protein levels. The V5-tag was introduced at the C-terminus of yNhANT4 in yeast strains as
shown. All yeasts were cultured in rich glucose media (YPD). (A) hANT4 mRNA level determined by real time PCR. ALG9 expression level was used to
normalize hANT4 expression. (B) hANT4 protein level in whole cells and isolated mitochondria was determined by western blotting using an anti-V5
epitope antibody. As a loading control, the membrane was immunostained with an anti-yeast porin antibody. WT: unmutated strains.
doi:10.1371/journal.pone.0019250.g006
Figure 7. ADP/ATP exchange kinetics of yNhANT4 A30V in
yeast mitochondria. The exchange reaction was initiated by adding
various concentrations of ADP to freshly isolated mitochondria. The
initial linear part of the kinetic curve was used as the initial velocity for
the ATP efflux rate. The initial velocity was plotted against the substrate
concentration [free ADP] using a 4-parameter logistic fit to describe the
data shown here.
doi:10.1371/journal.pone.0019250.g007
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strain (yAAC2). For making the chimeric DNA fragment of
containing the 59His-AAC2 N-terminal with hANTs, genomic
DNA from (yAAC2) was used as the PCR template and amplified
with primer sets F1+yNR. Each hANT ORF was amplified with
primers that contained the reverse complement sequence of yNR
for the forward primer (yNRhANTs-F) and F2 as a reverse
primer (F2ANTs-R). Three of the PCR products (HisAAC2 N-
terminus with 59 arm, each hANT ORF and F2+R2 fragment for
39 arm) were combined and amplified using primer set F1+R2.
The PCR generated knock-in constructs were transformed into
AAC null yeast (URA-AAC2). Transformants were selected on 5-
FOA plates. Insertion of the targeted DNA construct into AAC2
was verified by PCR and the ORF of the locus was sequenced.
Primer sequences denoted above are listed in supplemental
Table S1.
Plasmid constructions
pESC-Leu2d empty vector was obtained from Jay D. Keasling
(U of California) (Addgene plasmid 20120) [26]. The yNhANT4
and yNhANT2 ORFs were PCR amplified with the following
primers containing Xho1 and Nhe1 sites: forward Xho1yNF for
both yNhANT4 and yNhANT2; reverse Nhe1hA4R for yN-
hANT4, Nhe1hA2R for yNhANT2. PCR fragments were cloned
into pESC-Leu2d empty vector using the Xho1 and Nhe1 sites.
Primer sequences denoted above are listed in supplemental
Table S1.
Ethyl methanesulfonate (EMS) mutagenesis
Yeast cells were washed with 0.1 M sodium phosphate (pH 7.0),
and resuspended in 1.7 ml of this buffer supplemented with 50 ml
EMS (Sigma). After one hour of incubation at 30uC, 50% of the
cells were still alive, and mutagenesis was stopped by adding 8 ml
of 5% w/v sodium thiosulfate. Cells were plated on YPEG media
at a variety of dilutions and incubated at 30uC until colonies
appeared.
V5 tagging hANT4
The V5-tag epitope (GKPIPNPLLGLDST) [27] was intro-
duced at the C-terminus of yNhANT4 by homologous recombi-
nation. First, the ADH1 terminator sequence and KanR cassette
were PCR amplified with a forward primer containing the V5-tag
sequence (V5F) and a reverse primer containing the immediate
downstream sequence of the AAC2 ORF (V5R). Plasmid
pKT0127 was used as a template DNA (kind gift of Kurt S.
Thorn (Harvard U) (Addgene plasmid 8728)). To add the 59
homologous arm, the PCR product was further amplified with a
forward primer containing 40 bp of 39 sequence of hANT4 ORF
excluding stop codon (hANT4V5F). PCR generated DNA
fragments were transformed into yNhANT4 yeast and each of
Table 3. ADP/ATP exchange kinetics of hANTs measured on
isolated yeast mitochondria.
Strain KM Vmax
mM [free ADP] nmolATP/min/mg ANT
yAAC2 1.1 1430
yNhAnt1 2.7 1190
yNhAnt2 5.5 1640
yNhAnt3 7.6 1300
yNhAnt4 A30V 1.9 950
yNhAnt4 P95S 10 1650
yNhAnt4 S202L 0.96 270
The given values are the average of at least two independent experiments. The
standard error values were less than 10% for KM and 20% for Vmax.
doi:10.1371/journal.pone.0019250.t003
Figure 8. Location of hANT4 mutation sites in the bovine ANT1
structure. Based on primary amino acid sequence alignment (Fig. 4),
A30, P95 and S202 of hANT4 correspond to A18, P83 and A190 of
bovine ANT1, respectively. Those sites are highlighted in yellow on the
bovine ANT1 structure (Protein Data Bank ID: 1OKC). The ANT1 crystal
structure is oriented to show the inter membrane space at the top and
the mitochondrial matrix at the bottom (A). Panel B is rotated 90
degrees about a horizontal axis in the plane of the page compared to
panel A to show the ANT1 region facing the cytoplasm. Panel C shows
how fatty acid detergent elements are in close proximity to a specific
position in the ANT1 crystal structure (S202 in ANT4, A190 in ANT1).
doi:10.1371/journal.pone.0019250.g008
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containing G418. The V5-tagged hANT4 ORF in each clone was
verified by sequencing. Primer sequences denoted above are listed
in supplemental Table S1.
Isolation of yeast mitochondria
Mitochondrial isolation was performed by standard protocols
[28,29]. Yeast strains were treated with zymolyase (Seikagaku
America) to generate spheroplasts, and then broken with a Dounce
homogenizer. Mitochondria were collected by differential centri-
fugation.
Western blotting
Total protein was separated with sodium dodecyl sulfate–12%
polyacrylamide gel electrophoresis and then transferred to a
nitrocellulose membrane. The following were used as primary
antibodies: anti V5-tag (Invitrogen), anti Porin (Invitrogen) and
anti His-tag (Cell Signaling). Peroxidase-conjugated immunoglob-
ulin G (Cell Signaling) was used as the secondary antibody
followed by enhanced chemiluminescence (ECL) detection
(Thermoscientific).
Real-time PCR
Total RNA was isolated from spheroplasts using the RNA
aqueous kit (Ambion) and treated with DNAase I using Turbo
DNA free kit (Ambion). cDNA was synthesized using a high
capacity cDNA archive kit (Applied Biosystems). Real time PCR
was performed using SYBR green master mix (Applied
Biosystems) with gene specific primers; for hANT4, primer set
hANT4F and hANT4R and for ALG9, primer set ALG9F and
ALG9R were used. ALG9 expression was used as reference gene
to normalize hANT4 expression level [30]. Normalized expres-
sion was calculated by formula:{(Efficiency
hANT4)
CT hANT4/
(Efficiency
ALG9)
CT ALG9} using qGene software [31]. Primer
sequences denoted above are listed in supplemental Table S1.
ADP/ATP exchange assay in isolated mitochondria
The ADP/ATP exchange assays were performed essentially as
described [8] with a slight modification. Briefly, freshly isolated
mitochondria were added to reaction buffer (0.6 M mannitol,
0.1 mM EGTA, 2 mM MgCl2, 10 mM KPi, 5 mM a-ketogluta-
rate, 0.01 mM Ap5A, 10 mM Tris-HCl, pH 7.4) containing the
ATP detection system (2.5 mM glucose, hexokinase (2 E.U.),
glucose-6-phosphate dehydrogenase (2 E.U.), 0.2 mM NADP).
The exchange reaction was initiated by adding various concen-
trations of ADP. The ATP efflux rate was monitored continually
by monitoring the rate of NADPH formation (increase in
absorbance at 340 nm). The initial linear part of the kinetic curve
(first 3 minutes) was used to calculate the initial velocity, and the
substrate concentrations [free ADP] were calculated using the
program Win MAXC v2.51 created by Chris Patton (http://
stanford.edu/,cpatton/). The reactions volume was 200 ul, and
reactions were carried out in 96 well microtiter plates and read by
Synergy HT plate reader (BioTek). Kinetic parameters were
obtained by 4-parameter logistic fitting using Gen5 Data analysis
software (BioTek). The amount of ANT protein in the reaction
was quantified by western blotting using recombinant human His-
tagged ANT proteins as a standard. The density of the blot was
measured by using NIH ImageJ software (http://rsbweb.nih.gov/
ij/index.html).
Supporting Information
Figure S1 Codon-optimized hANT4 sequence for yeast expres-
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